Scientists at the Oklahoma Medical Research Foundation have identified a compound that shows promise in treating Huntington’s disease. They are now performing pre-clinical tests to assess whether the chemical slows the progress of the deadly disease of the nervous system. Led by Kenneth Hensley, Ph.D., OMRF researchers are performing pre-clinical tests using lanthionine ketimine (LK), […]
✕
